Sumary of FDA official hopeful younger kids can get shots this year:
- The Food and Drug Administration’s vaccine chief said Friday the agency will rapidly evaluate COVID-19 vaccinations for younger children as soon as it gets the needed data — and won’t cut corners.
- Dr. Peter Marks told The Associated Press he is “very, very hopeful” that vaccinations for 5- to 11-year-olds will be underway by year’s end.
- Maybe sooner: One company, Pfizer, is expected to turn over its study results by the end of September, and Marks say the agency hopefully could analyze them “in a matter of weeks.
- ”In the U.S., anyone 12 and older is eligible for COVID-19 vaccines.
- But with schools reopening and the delta variant causing more infections among kids, many parents are anxiously wondering when younger children can get the shots.
- Pfizer’s German partner BioNTech told weekly Der Spiegel Friday that it was on track “in the coming weeks” to seek approval of the companies’ COVID-19 vaccine for 5- to 11-year-olds.
- FDA’s Marks spoke with the AP Friday about the steps involved in clearing pediatric vaccines.
- Q: Many parents had hoped for vaccines for children under 12 by the time schools reopened.